Brickell Biotech Inc reports results for the quarter ended in December - Earnings Summary

Fresh Tracks Therapeutics

15/03/2022 13:33

* Brickell Biotech Inc  BBI.OQ  reported a quarterly
adjusted loss
of 6 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue rose 285.2% to $104.00 thousand from a year ago; 
analysts expected $154.75 thousand. 
    * Brickell Biotech Inc's reported EPS for the quarter was a
loss
of 6 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Brickell Biotech Inc shares had risen by 3.8% this
quarter.
    * The company reported a quarterly loss of $6.07 million.
    * Wall Street's median 12-month price target for Brickell
Biotech
Inc is $4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 15 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated